SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-23-006175
Filing Date
2023-05-08
Accepted
2023-05-08 16:29:34
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_033123.htm   iXBRL 10-Q 1057242
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 13749
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 13791
4 CERTIFICATIONS OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS ex32-01.htm EX-32.01 7537
  Complete submission text file 0001387131-23-006175.txt   5497046

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20230331.xsd EX-101.SCH 54900
6 XBRL CALCULATION FILE tnxp-20230331_cal.xml EX-101.CAL 54006
7 XBRL DEFINITION FILE tnxp-20230331_def.xml EX-101.DEF 219118
8 XBRL LABEL FILE tnxp-20230331_lab.xml EX-101.LAB 362862
9 XBRL PRESENTATION FILE tnxp-20230331_pre.xml EX-101.PRE 309926
75 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_033123_htm.xml XML 744260
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 23898204
SIC: 2834 Pharmaceutical Preparations